Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research focused on Cell biology and Pharmacokinetics, with related work in Metastatic breast cancer, Single-nucleotide polymorphism, Microvesicles. Notable publications include 'Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after...', 'Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics', and 'Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial'.
<scp>GABA</scp> ameliorates diet‐induced hepatic steatosis and insulin resistance by inhibiting macrophage activation
Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury
Corrigendum to “Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury” [Redox Biol. 41 (2021) 101932/PMID:33714739]
Associations between GUCY1A3 genetic polymorphisms and large artery atherosclerotic stroke risk in Chinese Han population: a case-control study
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics